On February 12, 2024, Skye Bioscience, Inc., closed the transaction. The company has raised $49,991,010 from 11 investors. The company paid sales commission of $3,499,371 in the transaction.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.06 USD | -2.30% | -2.83% | +316.18% |
May. 10 | Skye Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 23 | Skye Bioscience, Inc.(NasdaqGM:SKYE) added to NASDAQ Transportation Index | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+316.18% | 318M | |
+55.55% | 59.28B | |
+42.44% | 40.94B | |
-4.71% | 40.17B | |
-5.56% | 28.69B | |
+13.76% | 26.63B | |
-22.00% | 18.89B | |
+31.50% | 12.46B | |
+2.16% | 12.42B | |
+25.70% | 12.26B |
- Stock Market
- Equities
- EMBI Stock
- News Skye Bioscience, Inc.
- Skye Bioscience, Inc. announced that it has received $49.99101 million in funding